Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Notably, a similar a strategy has been successfully applied for the design of noncovalent inhibitors targeting the doorstop pocket of the thioredoxin glutathione reductase from Schistosoma mansoni (Petukhova et al., 2023)
Both belong to a new generation of injectable peptide-based therapies that work by targeting multiple hormonal pathways simultaneously, offering potentially greater metabolic benefits than earlier single-receptor agents
Unlike the DAC version, Mod GRF 1-29 lacks the binding agent DAC, which greatly extends a peptides half-life
Light exposure deserves careful attention
US$ 20.78
US$ 25.02
US$ 26.85
US$ 29.43
:max_bytes(150000):strip_icc()/VWH-Zepbound-a91ec7a305e8407d83daa7b41039b4aa.jpg)
US$ 25.32
